Research / DVLT / Fundamental state Inspectable configuration
State dimensions Filing 0001104659-21-065188 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
48.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.25% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-240.33% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
180.54% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
285.86% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
25.59% · CORE · VALID
Operating margin 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-235.91% · CORE · VALID
R&D intensity 0th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
101.73% · OPTIONAL · VALID
SBC intensity 64th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
22.03% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 27.79%
Current 48.74%
Delta 20.96% Capex Intensity Increased
Previous 2.16%
Current 2.25%
Delta 0.09% Cash Generation Increased
Previous -410.11%
Current -240.33%
Delta 169.78% Growth Increased
Previous 44.30%
Current 180.54%
Delta 136.24% Inventory Pressure Increased
Previous 112.65%
Current 285.86%
Delta 173.22% Margin Increased
Previous 17.76%
Current 25.59%
Delta 7.82% Profitability Increased
Previous -469.51%
Current -235.91%
Delta 233.60% R And D Intensity Decreased
Previous 190.18%
Current 101.73%
Delta -88.45% Sbc Intensity Decreased
Previous 39.85%
Current 22.03%
Delta -17.82% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.